SCHEMBL21250145

SCHEMBL21250145

C/C=C(\C=N)Nc1ccncc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MDM2 Q00987 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ TAAR1 Q96RJ0 2/20 0.41
▸ EPHX1 P07099 1/20 0.41
▸ RAB9A P51151 2/20 0.40
▸ CTSD P07339 1/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ TYK2 P29597 2/20 0.39
▸ JAK2 O60674 1/20 0.39
▸ GAA P10253 1/20 0.38
▸ BCHE P06276 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ PKM P14618 1/20 0.38
▸ HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25516100 0.80 MDM2 (0.47) MDM2KDM4EL3MBTL1TAAR1EPHX1
SCHEMBL12407894 0.80 MDM2 (0.52) MDM2KDM4EL3MBTL1TAAR1EPHX1
SCHEMBL21250146 0.78 TP53 (0.49) KDM4ERAB9AKMT2AMEN1PKM
SCHEMBL23866015 0.72 CTSD (0.35) MDM2KDM4EL3MBTL1TAAR1EPHX1
SCHEMBL1343362 0.69 MDM2 (0.59) MDM2KDM4EL3MBTL1TAAR1EPHX1
SCHEMBL15131704 0.69 MDM2 (0.58) MDM2KDM4EL3MBTL1TAAR1EPHX1
SCHEMBL25453609 0.69 TAAR1 (0.39) MDM2TAAR1RAB9AKMT2AMEN1
SCHEMBL14404748 0.67 MAPT (0.56) MDM2KDM4EL3MBTL1TAAR1EPHX1
SCHEMBL21746628 0.66 MDM2 (0.40) MDM2KDM4EL3MBTL1TAAR1EPHX1
SCHEMBL48610 0.66 TSHR (0.69) MDM2KDM4EL3MBTL1TAAR1EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10381578-B2 Organometallic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-08-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10381578-B2 Organometallic compound and organic light-emitting device including the same L1CAM, MSL1, CHRM1 MDM2 678/4885KDM4E 2858/4885L3MBTL1 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback